Ann: Update on Admedus shaped patch product franchise, page-26

Many here may think I am very negative about AHZ - not the case with their products but I think there marketing and sales strategy is wrong.
They are not a gorilla in the health landscape - they are hampered by cash constraints .

My thoughts is that they need to do collaborations with the major players.
Keep the ADAPT tech tightly held but licence it to those majors in the different fields - coronary, vascular etc
Clip the ticket as others pay for the development sales and marketing

Ditch their sales team - too many products to market not enough feet on the ground in the surgeons faces .

This way sales will increase . I just can't see they are going to get volume .
Volume is what it is all about . Profits will increase . Costs reduce .

Bit like writing a book and trying to publish and sell it yourself . The author gets a royalty the publisher takes the risk.